Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Different index types suit different strategies. This concise guide highlights when to use each type to align with your investment objectives.
20,296 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Two 2x MicroStrategy ETFs, MSTX and MSTU, are under renewed scrutiny as volatility tests the funds' synthetic exposur...
If you're worried about market crash? you're not alone. This guide explains how investing in three reliable dividend ...
June 2026 brings a surprising shift: the market shows the strongest sign housing market signals in years. This articl...
A dramatic shift in Tesla governance is underway. Elon Musk just lifted his voting stake, fueling questions about con...
Two traditional industrial leaders have surged while Tesla faced a bumpy year. This deep dive explains how Caterpilla...
New market analysis shows SPXL’s 3x exposure often falls short of its target because of daily resets and volatility d...
As defense budgets surge in 2026, SHLD and XAR offer two distinct routes to ride the rearmament boom: a global tech t...
A data center spending surge across AI giants is reshaping markets. This article explains how a single company could ...
A 73-year-old’s bid to hedge inflation with gold inside a traditional IRA backfires when required minimum distributio...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
As markets wobble in early 2026, investors are increasingly pursuing a hybrid approach that blends bonds and dividend...